Chromic picolinate treatment

Details Chromic picolinate treatment Chromic picolinate treatment

1991-12-09

1992-12-29

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514824, A61K 31555

Patent

active

051751569

ABSTRACT:
The administration of chromic picolinate, preferably in the form of chromic tripicolinate, as a prophylactic or therapeutic agent for controlling various blood serum parameters. In particular, the administration is for controlling blood serum lipid levels, including the lowering of undesirably high blood serum LDL-cholesterol levels and the raising of blood serum HDL-cholesterol levels. Additionally, the administration is for controlling undesirable high blood serum glucose levels, this being particularly applicable for the treatment of maturity-onset diabetes. Additionally, chromic picolinate, preferably in the form of chromic tripicolinate, is administered to facilitate uptake of amino acids by skeletal muscle. Thus chromic picolinate can act as an effective anabolic agent.

REFERENCES:
patent: 4315927 (1982-02-01), Evans
patent: 4343905 (1982-08-01), Szalay
Present Knowledge in Nutrition, 5th Ed. The Nutrition Foundation (1984) pp. 571-582.
Boyle, et al., Southern Med., Jour. 70:1449-1453 (1977).
Anderson, R. W., Clin. Physiol. Biochem. 4:31-41 (1986).
Riales, R., in Chromium in Nutrition and Metabolism, Shapcott and Hybert, Eds., pp. 199-212 (1979).
Newman, H. A. I., et al., Clin. Chem. 24:541-544 (1978).
The Lipid Research Clinics Coronary Primary Prevention Trial Results, J.A.M.A. (J. Amer. Med. Assn.) 251:351-364 (1984).
Recommended Dietary Alowances, 9th Revised Ed., The National Academy of Sciences p. 159-161 (1980).
Albers, J. J., et al., Clin. Chem. 24:853-856 (1978).
Friedewald, W. T., Clin. Chem. 18:499-502 (1972).
Naito, H. K., J. Clin. Immunoassay 9:11-20 (1986).
Clegg, M. D. and Schroeder, W. A., J. Amer. Chem. Soc. 81:6065-6069 (1959).
Hills, M., et al., Brit. Jour. Clin. Pharmacol. 8:7-20 (1979).
Newman, W. P., et al., New England J. of Med. 314:138-144 (1986).
Avogaro, P., et al., Artery 4:385-394 (1978).
Sniderman, A., et al., Proc. Natl. Acad. Sci. U.S.A. 77:604-608 (1980).
Riesen, W. F., et al., Atherosclerosis 37:157-162 (1980).
De Backer, G., et al., Atherosclerosis 42:197-203 (1982).
Maciejko, J. J., et al., New Engl. J. Med. 309:385-389 (1983).
Schmidt, S. B., et al., Am. J. Cardio. 55:1459-1462 (1985).
Press, R. I., et al. Western Journal of Medicine 12:41-45 (1990).
Kwiterovich, P. O., et al., Preventive Medicine 12:815-834 (1983).
Brunzell, J. D. et al., Atherosclerosis 4:79-83 (1984).
Evans, G. W., et al., International Journal of Biosocial and Medical Research 11(2): 163-180 (1989).
Anderson, R. A. et al., Amer. J. Clin. Nutr. 41:1177-1183 (1985).
Scahller, K. H., At Absorption Newsletter 12:147-150 (1973).
Evans, G. W., Pediatric Res. 14:876-880 (1980).
Offenbacher, E. G. and Pi-Sunyer, F. X., Ann Rev. Nutr. 8:543-563 (1988).
Seal, C. J. and Heaton, F. W., (1983) Brit. Journal of Nutrition 50:317-324.
Chemical Abstracts Citation 88:163086, Russian Publication (1977).
Toepfer, E. W. et al., J. Agr. Food Chem. 21(1): 69-73 (1973).
McCarthy, M. F. Medical Hypothesis 6:1177-1189, (1980).
Anderson, R. A., et al., Metabolism 32(9):894-899 (1983).
Offenbacher, E. G., et al., Diabetes 29:919-925 (1980).
Elwood, J. C., et al., J. Amer. Coll. of Nutri. 1:263-274 (1982).
Abraham, A., et al., The Amer. J. of Clin. Nutri. 33:2294-2298 (1980).
Simonoff, M., et al., Biolog. Trace Element Res. 6:431-439 (1984).
NIH Report of Plasma Lipid Distribution in Selected North American Populations (1984).
Anderson, R. "Trace Elements in Health and Disease" Skandia Symposia Oct. 23-25, 1984, pp. 110-119.
Chen, N. J. Nutr. 103:1182-1186 (1973).
Davidson, I., et al. Proc. Soc. Exp. Med. Biol. 127:66-70 (1967).
Gonzales-Vergara, E., et al. Israel Journal of Chemistry 21:18-22 (1981).
Mirsky, N. Journal of Inorganic Biochemistry 13:11-21 (1980).
Tuman, R. Diabetes 27:49-56 (1978).
Yamamoto, A. Toxicology and Applied Pharmacology 59:515-523 (1981).
Yamamoto, A., et al. Jour. of Inorganic Biochemistry 22:91-102 (1984).
Nutrition 21 Consumer Education Brochure: "The Prophylactic and Therapeutic Potential of Chromium Picolinate in Diabetes, Hyperlipidemia, Anabolism and Weight Reduction" (1989).

Affiliated with

Also associated with

Rating

Chromic picolinate treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chromic picolinate treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromic picolinate treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1887186